Apellis Pharmaceuticals Inc (NASDAQ: APLS) Stock In Prove Me State
Apellis Pharmaceuticals Inc (APLS) concluded trading on Thursday at a closing price of $32.74, with 2.4 million shares of worth about $78.54 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -23.07% during that period and on December 12, 2024 the price saw a […]
Investors Should Take Note Of Apellis Pharmaceuticals Inc (APLS)
Apellis Pharmaceuticals Inc (APLS) concluded trading on Thursday at a closing price of $33.45, with 5.05 million shares of worth about $168.84 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -18.51% during that period and on December 05, 2024 the price saw a […]
These Numbers Could Change Investor Views For Apellis Pharmaceuticals Inc (NASDAQ: APLS)
Currently, there are 119.56M common shares owned by the public and among those 100.96M shares have been available to trade. The company’s stock has a 5-day price change of -11.49% and -32.79% over the past three months. APLS shares are trading -56.26% year to date (YTD), with the 12-month market performance down to -45.33% lower. […]
Is There More Upside Ahead For Apellis Pharmaceuticals Inc (NASDAQ: APLS)
Apellis Pharmaceuticals Inc (APLS) concluded trading on Thursday at a closing price of $28.06, with 5.51 million shares of worth about $154.71 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -33.19% during that period and on November 14, 2024 the price saw a […]
Why Should You Put Apellis Pharmaceuticals Inc (NASDAQ: APLS) On Your Portfolio?
Currently, there are 119.56M common shares owned by the public and among those 100.98M shares have been available to trade. The company’s stock has a 5-day price change of 4.46% and -18.66% over the past three months. APLS shares are trading -52.29% year to date (YTD), with the 12-month market performance down to -42.09% lower. […]
Apellis Pharmaceuticals Inc (NASDAQ: APLS) Loses -62.80% From High. Why That Could Change?
Currently, there are 119.56M common shares owned by the public and among those 100.98M shares have been available to trade. The company’s stock has a 5-day price change of -4.82% and -26.88% over the past three months. APLS shares are trading -54.14% year to date (YTD), with the 12-month market performance down to -30.75% lower. […]
Look At Analyst Expectations For A Better Read On Apellis Pharmaceuticals Inc (NASDAQ: APLS)
Currently, there are 119.56M common shares owned by the public and among those 101.06M shares have been available to trade. The company’s stock has a 5-day price change of -9.79% and -20.70% over the past three months. APLS shares are trading -53.66% year to date (YTD), with the 12-month market performance down to -27.08% lower. […]
Are Analysts Expecting A Better 2020 For Apellis Pharmaceuticals Inc (APLS)?
Apellis Pharmaceuticals Inc (APLS) concluded trading on Thursday at a closing price of $68.12, with 2.62 million shares of worth about $178.14 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 181.84% during that period and on Thursday the price saw a gain of […]
